Nightingale Health to establish a laboratory in the United States with Weill Cornell Medicine as the first customer
Press release, 16 April 2024 at 08:45 a.m. (EEST) Nightingale Health, a pioneer in health risk detection and preventative health, announces today that it will open a laboratory in the United States. Additionally, Nightingale Health and the Englander Institute for Precision Medicine at Weill Cornell Medicine have signed a Letter of Intent in which the parties agree to collaborate on the adoption of Nightingale Health’s proprietary technology in healthcare and medical research in the United States. The Englander Institute for Precision Medicine is a translational research hub at Weill